Apellis Pharmaceuticals Inc (APLS) Q3 2024 Earnings Report Preview: What to Look...

Published on 4 Nov 2024 on GuruFocus.com · via Yahoo Finance

Apellis Pharmaceuticals Inc (NASDAQ:APLS) is set to release its Q3 2024 earnings on Nov 5, 2024. The...

Read the rest of the article

Start tracking your investments with Statfolio

PGIM Jennison Health Sciences Fund recently released its third quarter 2024 investor letter. A co...

Insider Monkey · via Yahoo Finance 12 Dec 2024

Apellis Pharmaceuticals (NASDAQ: NASDAQ:APLS) discussed its third-quarter financial performance...

Investing.com 6 Nov 2024

Apellis shares plunge 13% on wider-than-feared Q3 loss, revenue miss

Investing.com 5 Nov 2024

Release Date: November 05, 2024 For the complete transcript of the earnings call, please refer to...

GuruFocus.com · via Yahoo Finance 5 Nov 2024

Apellis Pharmaceuticals Inc (NASDAQ:APLS) is set to release its Q3 2024 earnings on Nov 5, 2024. ...

GuruFocus.com · via Yahoo Finance 4 Nov 2024

We recently compiled a list of the 10 Largest Biotech Hedge Funds and Their Top Stock Picks. In t...

Insider Monkey · via Yahoo Finance 19 Sep 2024

There's been a notable change in appetite for Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) shares ...

Simply Wall St. via Yahoo Finance 9 May 2024

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q1 2024 Earnings Call Transcript May 7, 2024 Apellis ...

Insider Monkey via Yahoo Finance 9 May 2024

For the quarter ended March 2024, Apellis Pharmaceuticals, Inc. (APLS) reported revenue of $172.3...

Zacks via Yahoo Finance 8 May 2024

Apellis Pharmaceuticals, Inc. APLS incurred a first-quarter 2024 loss of 54 cents per share, whic...

Zacks via Yahoo Finance 8 May 2024